Concerning releasing health-care test results to patients.
SB 26-162, the Sensitive Test Results Protection Act, would delay the automatic release of certain “sensitive test results” to a patient’s electronic health record or patient portal for three business days after the results are finalized. The bill applies only to pathology or radiology reports ordered to diagnose or monitor cancer, and to test results that may reveal a genetic marker related to a cancer condition. It creates two exceptions: results may be released immediately if the patient’s physician or treating health-care provider authorizes early release, or if the patient specifically asks to receive those results without delay.
The bill is framed as a patient-protection measure intended to give clinicians time to review potentially distressing or unexpected results before patients see them online. Its legislative declaration states that immediate electronic release can cause confusion or unnecessary anxiety, and that a brief delay would allow providers to explain prognosis, treatment options, and support resources. The bill also states that compliance with its delay requirement is not “information blocking” under federal law and shields persons administering electronic health records from civil, criminal, administrative, or professional disciplinary liability for failing to comply with the section.
In practical terms, the bill would amend Colorado law by adding a new section to Title 12 governing the timing of release of certain health information beginning July 1, 2027. It would require the custodian or administrator of an electronic health record system to implement the delay and would create a state-law exception to the general federal push for immediate patient access to electronic health information. The measure is narrowly targeted to cancer-related pathology, radiology, and genetic-marker results rather than all lab results or all medical records.
The general sentiment reflected in the bill text is supportive of a limited delay to protect patients from receiving highly sensitive results without clinical context. The bill’s sponsors appear to view the change as a balance between patient access and emotional/medical support. At the same time, the bill’s last recorded action—postponement indefinitely in the House Committee on Health & Human Services—suggests the proposal faced resistance or did not advance, though no committee transcript or vote record is provided here.
The main point of contention is the tension between immediate patient access to health information and the desire to let clinicians review sensitive cancer-related results first. Supporters emphasize reducing confusion, distress, and the risk of patients misinterpreting results on their own; critics or skeptics may be concerned that any delay conflicts with transparency goals, patient autonomy, or federal interoperability and access expectations. The bill also implicitly raises implementation concerns for hospitals, clinics, and electronic health record vendors that would need to configure systems to hold back only certain categories of results while preserving exceptions for provider- or patient-requested immediate release.
The bill would add a new section to Colorado law establishing a three-business-day delay for the release of specified cancer-related pathology, radiology, and genetic-marker test results through electronic health records and patient portals, effective July 1, 2027. It would require the custodian or administrator of an electronic health record system to implement the delay, while expressly stating that compliance is not information blocking under federal law and that failure to comply does not create civil, criminal, administrative, or professional disciplinary liability under the section.
The bill’s stated purpose and findings reflect a generally supportive, patient-protection-oriented sentiment: it seeks to reduce distress and allow clinicians to explain sensitive results before patients see them online. However, the bill’s procedural outcome—postponed indefinitely in the House Committee on Health & Human Services—indicates that it did not receive enough support to advance, suggesting at least some legislative hesitation about the policy or its implementation.
The central contention is whether sensitive cancer-related test results should be delayed to allow clinician review or released immediately to preserve patient access and transparency. Supporters argue that a short delay helps patients understand alarming or unexpected results and receive guidance; opponents may view the delay as paternalistic, potentially inconsistent with federal health-information access norms, or burdensome for health systems. Additional concerns likely involve how electronic health record systems would identify covered results and apply the exceptions for provider-authorized or patient-requested immediate release.